Accutane Pregnancy Exposure May Have Increased Under Risk Management Plan, FDA Says

During the first year of the SMART program, there were 120 pregnancy exposures, compared to 127 in the year prior to implementation of Roche's enhanced risk management program. The 23% decrease in prescriptions for the severe acne treatment suggests a relative increase in exposure.